live
We're Lytix
Why spend the last 30% of your life in pain?
Lytix is a pioneering biotech company revolutionizing aging-related disease treatment through targeted cell therapy. Their innovative approach utilizes chimeric antigen receptor NK (CAR-NK) cells to specifically identify and eliminate senescent cells, associated with numerous age-related ailments. By focusing on precision and safety, Lytix aims to develop effective treatments that improve longevity and quality of life. With a vision for widespread accessibility, they aspire to make age-related therapies affordable and accessible to all, transforming the landscape of aging care.
Our Science
Senescent Cell Targets
Senescent cells can be targeted through specific protein biomarkers located on the extracellular surface of the cells. By targeting these protein biomarkers, we are able to elicit a response from the immune system. We achieve our results by removing these cells.
CAR-NK Cells
We engineer natural killer cells to express chimeric antigen receptors targeting these protein biomarkers. By using known antibody sequences, we engineer our receptor to effectively target and remove senescent cells from the body. These cells are transfused into the patient for initiating the therapy.
FAQ
About the Founders
Divyan Bavan
I'm interested in solving biological problems using our immune system and machine learning. To contribute to the field, I have built projects to model proteomic properties, predict T cell interactions, and created a new therapeutic for pancreatic cancer. I've also worked in a lab doing experiments to classify protein interactions.
Lillian Li
As someone passionate about cell biology and specifically cellular senescence and longevity, I have built models for cell checkpoints and written papers about how this ties into senescence and stem cells. Additionally, I've worked in a lab to study cancerous cells and their relation to viruses and proteins.
Lytix
Lytix is a company trying to create a better future for our aging population. We use the innovative solutions from cancer therapy and implement them into the field of longevity.
Terms and conditions
©2022 - Typedream | All right reserved